Skip to content

Clinical research

Clinical trial sites in Italy

Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.

  • Trial site
  • Group of pins (click to zoom)

Showing the 40,000 busiest of 48,775 located sites. The map holds only the first 40,000, so narrow the filters to see the rest.

Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.

Looking for contract research suppliers and CROs? Visit Contract Research Map

Looking to track new and ongoing clinical trials? Visit Trial Insights

Filters: Country: Italy Clear all

Trial sites by region

Select a bar to filter by region.

Scale
Trial sites by region
CategoryTrial sites
Europe48,775

Top countries

Country of the site's address. Select a bar to filter.

Scale

Bar colour shows the country's region, as in the chart by region.

Trial sites by country
CategoryTrial sites
United States308,118
France73,405
Germany73,289
Italy48,775
China46,344
Japan38,886
Spain36,628
United Kingdom32,520

Trial sites

48,775 sites. Sites with a public page link to it on Pharma Observatory.

  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 2009) Meldola, Forli-Cesena, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 2107) Meldola, Forli-Cesena, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 0879) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1454) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1806) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1807) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 2302) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 3207) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 5207) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 7207) Meldola, Emilia-Romagna, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Scientifico Romagnolo Per lo Studio e la Cura Dei Tumori (I.R.S.T.) Meldola (FC), Italy 1 trial
  • IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori Cesena, Italy 1 trial
  • IRCCS - Istituto Scientifico Romagnolo per lo Studio dei Tumori - Dino Amadori - Srl Meldola, Fc, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Scientifico Romagnolo per lo Studio e La Cura Dei Tumori ISRT Meldola, Italy Ongoing trial 1 trial
  • IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, Ravenna, Italy 1 trial
  • IRCCS - Istituto di Ricovero e Cura a Carattere Scientifico 'Casa Sollievo della Sofferenza' San Giovanni Rotondo, Italy 1 trial
  • IRCCS - Istuto di Recovero e Cura a Carattere Scientifico Verona, Vento, Italy 1 trial
  • IRCCS - Pol. San Matteo Pavia, Italy 1 trial
  • IRCCS - Policlinico Universitario S.Orsola - Malpighi Bologna, Italy 1 trial
  • IRCCS - Policlinico Universitario di Sant'Orsola Bologna, Italy, Italy Ongoing trial 1 trial

Explore the data behind the map on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.